Skip to content
Trial Eligibility
Menu

Genetic Studies of Insulin and Diabetes

NCT00001987

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The study will allow researchers to obtain blood, plasma, DNA, and RNA for genetic studies of insulin. There will be a focus on the causes of insulin resistance and diabetes mellitus. Insulin is a hormone found in the body that controls the level of sugar in the blood. Insulin resistance refers to conditions like diabetes when insulin does not work properly. In this study researchers would like to compare patients with diabetes and other forms of insulin resistance to normal individuals. The study will investigate how insulin attaches to cells.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Diabetes Mellitus
  • Severe Insulin Resistance

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
6 months to 120 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Last updated on ClinicalTrials.gov
October 8, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • National Institutes of Health Clinical Center · Bethesda, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.